ClinConnect ClinConnect Logo
Search / Trial NCT05715021

RCT Evaluating First Time Shoulder Dislocation

Launched by MCMASTER UNIVERSITY · Jan 27, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how to best treat patients who experience their first shoulder dislocation, which often happens during sports or physical activities. Researchers want to compare two approaches: one group will receive a surgical procedure called arthroscopic soft tissue stabilization to help prevent future dislocations, while the other group will follow a non-surgical management plan. The goal is to find out which method reduces the chances of the shoulder dislocating again and improves overall shoulder function over a period of two years.

To participate in this study, individuals must be between 14 and 40 years old and have had a first-time shoulder dislocation within the last three months. They will need to provide consent to join the trial. However, some people may not be eligible, such as those who cannot have surgery, have previous shoulder surgeries, or have certain other medical conditions. Participants in this trial can expect regular follow-up appointments to monitor their progress and help the researchers gather valuable information on the effectiveness of these treatment options.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients ages 14-40 years;
  • 2. Diagnosis of first-time shoulder anterior dislocation having occurred within the past 3 months confirmed either by radiographic evidence or documented reduction of anterior shoulder dislocation as well as physical examination eliciting unwanted glenohumeral translation with reproduction of symptoms;
  • 3. Provision of informed consent.
  • Exclusion Criteria:
  • 1. Patients that cannot undergo surgery or anesthesia;
  • 2. Patients with concomitant injuries (rotator cuff tear, fracture)
  • 3. Previous shoulder surgery;
  • 4. Patients that will likely have problems with maintaining follow-up or are incarcerated;
  • 5. Epilepsy/seizure disorder;
  • 6. Pregnancy;
  • 7. Diagnosis of multidirectional instability;
  • 8. Bony glenoid defect (bony Bankart) \>10% as measured on preop imaging;
  • 9. Dislocation without trauma, in a context of hyper laxity or atraumatic instability;
  • 10. Cases involving litigation or workplace insurance claims (e.g., WSIB).

About Mcmaster University

McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.

Locations

Hamilton, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Moin Khan, MD

Principal Investigator

McMaster University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials